IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 16 filers reported holding IMMUNE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Intellectus Partners, LLC | 31,082 | $11,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 86,325 | $30,000 | 0.00% |
| VANGUARD GROUP INC | 136,841 | $48,000 | 0.00% |
| UBS Group AG | 15,648 | $5,000 | 0.00% |
| Advisor Group, Inc. | 3,750 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 23,514 | $8,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 22,355 | $7,000 | 0.00% |
| CREDIT SUISSE AG/ | 33,399 | $11,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 28,405 | $10,000 | 0.00% |
| MORGAN STANLEY | 2,749 | $1,000 | 0.00% |